This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
CP
Not CommonAI-Generated
Chromium Picolinate Source
Coccinia grandis
Diabetes management in Ayurveda and Southeast Asian medicine
How does Coccinia grandis work to lower blood sugar levels?
Coccinia grandis works through multiple mechanisms to support healthy blood sugar levels. The herb contains chromium, an essential trace mineral that enhances insulin sensitivity by improving insulin receptor function. Additionally, compounds like pectin and saponins may slow carbohydrate absorption in the digestive tract. The herb also demonstrates insulin-mimetic properties, meaning it can mimic some of insulin's effects on glucose uptake by cells. These combined actions help improve glucose metabolism and utilization. Evidence level C supports these mechanisms based on pharmacological studies and traditional use.
Can Coccinia grandis interact with diabetes medications like metformin or insulin?
Yes, Coccinia grandis can interact with diabetes medications. Because this herb has blood sugar-lowering effects, combining it with insulin, metformin, sulfonylureas, or other antidiabetic medications may cause additive effects, potentially leading to hypoglycemia (dangerously low blood sugar). If you take any diabetes medications, consult your healthcare provider before using Coccinia grandis. Close monitoring of blood glucose levels is essential, and medication dosages may need adjustment to prevent adverse effects. Evidence level C supports these potential interactions based on pharmacological studies.
What is the recommended dosage of Coccinia grandis for blood sugar control?
The typical adult dosage for Coccinia grandis is 200-400mg of standardized leaf extract taken twice daily. Alternatively, fresh leaves can be consumed as a vegetable, which is common in South and Southeast Asian traditional medicine. Standardized extracts help ensure consistent chromium and active compound content. Dosage should be individualized based on blood glucose response and individual tolerance. Start with lower doses and gradually increase while monitoring blood sugar levels closely. Always follow product-specific recommendations or guidance from a qualified healthcare practitioner familiar with herbal medicine.
Is Coccinia grandis safe to take during pregnancy or breastfeeding?
Coccinia grandis is considered unsafe during pregnancy and breastfeeding and should be avoided. There is insufficient safety data regarding its use in pregnant or nursing women, and the herb's blood sugar-lowering effects could potentially harm fetal development or cause pregnancy complications. The chromium content and insulin-mimetic compounds may affect maternal glucose metabolism in ways that could impact both mother and baby. Women who are pregnant, planning pregnancy, or breastfeeding should not use Coccinia grandis supplements. Consult a qualified healthcare provider for safer alternatives for blood sugar management during pregnancy.
What are the side effects of Coccinia grandis supplements?
The most commonly reported side effects of Coccinia grandis include hypoglycemia (low blood sugar) and gastrointestinal disturbances such as nausea, bloating, or mild stomach discomfort. Hypoglycemia is more likely when the herb is combined with diabetes medications or taken in excessive doses. Some individuals may experience allergic reactions, though this is rare. To minimize side effects, start with lower doses, take supplements with food, and monitor blood sugar levels regularly. Discontinue use and seek medical attention if you experience symptoms of low blood sugar such as dizziness, confusion, sweating, or rapid heartbeat.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Coccinia grandis (ivy gourd) is a tropical plant used for food and therapeutic purposes, demonstrating antidiabetic, antioxidant, and hepatoprotective properties in various studies [PMID:41504092, PMID:36358590].
Background
Coccinia grandis, commonly known as ivy gourd, is a member of the Cucurbitaceae family widely distributed across Asia, Africa, and the Pacific Islands [PMID:38863541, PMID:24884680, PMID:35012237].
Traditional uses
Traditionally used to treat fever, leprosy, asthma, jaundice, bronchitis, hypertension, diabetes, cancer, ulcers, diarrhea, inflammation, burns, skin eruptions, insect bites, allergies, eye infections, and urinary disorders [PMID:35012237, PMID:41504092].
Active compounds
The plant contains secondary metabolites including flavonoids (such as rutin, kaempferol, and quercetin glycosides), phenolic acids (chlorogenic and p-coumaric acids), terpenoids (including lupeol and cucurbitacins), alkaloids, sterols, and glycosides [PMID:36358590, PMID:39931272, PMID:34945591, PMID:41760715].
Mechanism of action
Antidiabetic mechanisms include the induction of GLUT4 translocation in the absence of insulin via the PI3K pathway [PMID:26820984] and the inhibition of α-glucosidase [PMID:32678956]. Anti-inflammatory and anti-apoptotic effects are mediated through the downregulation of NF-κB, p38 MAPK, ERK1/2, and IL-6/JAK/STAT3 signaling cascades [PMID:32285384].
Clinical evidence
Evidence CType 2 Diabetes
Clinical trials studying hypoglycemic effects have shown conflicting results [PMID:25331834].
Evidence DHepatocellular Inflammation
Ethanol extract of leaves alleviated high-lipid diet induced hepatocellular inflammation and apoptosis in rats [PMID:35092065].
Evidence DHyperglycemia (Animal Model)
Combined extract of C. grandis and Blumea balsamifera demonstrated antidiabetic activity in streptozotocin-nicotinamide induced diabetic rats [PMID:39079440].
Evidence DAdipocyte Differentiation
Root extracts suppress adipocyte differentiation in 3T3-L1 cells [PMID:24884680].
Evidence summary
The evidence is primarily based on in vitro cell studies and animal models (Level D), with some review-level data (Level C) indicating conflicting results in human clinical trials regarding hypoglycemic effects.
PubMed sources
1.PMID: 35092065 (2022) — Coccinia grandis alleviates flavor-enhancing high-lipid diet induced hepatocellular inflammation and apoptosis. · Journal of food biochemistry
2.PMID: 26820984 (2016) — Biomolecular Characterization of Putative Antidiabetic Herbal Extracts. · PloS one
3.PMID: 35012237 (2022) — Mucilage of Coccinia grandis as an Efficient Natural Polymer-Based Pharmaceutical Excipient. · Polymers
4.PMID: 38863541 (2024) — Transcriptomics reveal useful resources for examining fruit development and variation in fruit size in Coccinia grandis. · Frontiers in plant science
5.PMID: 24884680 (2014) — Ivy gourd (Coccinia grandis L. Voigt) root suppresses adipocyte differentiation in 3T3-L1 cells. · Lipids in health and disease
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 36358590 (2022) — Identification and Quantification of Key Phytochemicals, Phytohormones, and Antioxidant Properties in Coccinia grandis during Fruit Ripening. · Antioxidants (Basel, Switzerland)
7.PMID: 41504092 (2025) — Ethnomedicinal Uses, Phytochemistry, Pharmacological Activity, Therapeutic Potentials, and Functional Foods of Coccinia grandis (L.) Voigt: An Updated Review. · Frontiers in bioscience (Elite edition)
8.PMID: 32285384 (2020) — Potential anti-inflammatory and anti-apoptotic effect of Coccinia grandis plant extract in LPS stimulated-THP-1 cells. · Environmental science and pollution research international
9.PMID: 32678956 (2020) — LC-QTOF-MS-based metabolite profiling and evaluation of α-glucosidase inhibitory kinetics of Coccinia grandis fruit. · Biomedical chromatography : BMC
10.PMID: 39931272 (2025) — UHPLC-HRMS/MS-Based Metabolic Profiling and Quantification of Phytochemicals in Different Parts of Coccinia grandis (L.) Voigt. · Food science & nutrition
11.PMID: 25331834 (2014) — The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? · Nutrition journal
12.PMID: 41760715 (2026) — Biological assessment of Coccinia grandis leaf and Lupeol against β-lactam resistant Klebsiella pneumoniae through integrated in-silico and in-vitro studies. · Scientific reports
13.PMID: 34945591 (2021) — LC-QTOF-MS/MS Based Molecular Networking Approach for the Isolation of α-Glucosidase Inhibitors and Virucidal Agents from Coccinia grandis (L.) Voigt. · Foods (Basel, Switzerland)
14.PMID: 39079440 (2024) — Antidiabetic effect of combined extract of Coccinia grandis and Blumea balsamifera on streptozotocin-nicotinamide induced diabetic rats. · Journal of Ayurveda and integrative medicine